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AaSTR^CT  Pertussis toxin  treatment of rabbit peritoneal  neutrophils causes a concentration- 
dependent inhibition  of granule enzyme secretion  induced  by formylmethionyl-leucyl-phen- 
ylalanine,  C5a,  and  leukotriene  B4.  It also  inhibits  chemotaxis  induced  by formylmethionyl- 
leucyl-phenylalanine.  The same toxin treatment,  however,  has no effect  on granule enzyme 
secretion  induced  by  the  calcium  ionophore  A23187  or  phorbol  12-myristate  13-acetate. 
Moreover,  pertussis  toxin  treatment  does  not  affect  either  the  number  or  affinity  of  the 
formylpeptide  receptors  on the  neutrophil  nor does  it  have  any effect  on the  unstimulated 
levels  of cyclic  AMP  (cAMP)  or  the  transient  rise  in  cAMP  induced  by  chemotactic  factor 
stimulation  in these cells. 
We hypothesize that pertussis toxin, as in other cells, interacts with a GTP binding regulatory 
protein  identical  with  or analogous to either  N~ or transducin  which  mediates the  receptor- 
induced inhibition or activation of a target protein or proteins required in neutrophil activation. 
The nature of the target protein is unknown, but it is not the catalytic unit of adenylate cyclase. 
The target protein acts after binding of chemotactic factor to its receptor in the sequence that 
leads to the receptor-induced  rise in intracellular Ca  2÷. It does not affect the responses elicited 
by the direct introduction  of calcium  into the cells or the activity of protein kinase C. 
Two GTP binding  regulatory proteins,  Ns(Gs) and  Ni(Gi), 
mediate the action of  a number of  hormones and other agents 
on adenylate cyclase.  The proteins involved have been puri- 
fied and studied in detail (1). Cholera toxin ADP-ribosylates 
and  activates  Ns  (2).  Pertussis  toxin  ADP-ribosylates and 
inactivates the  inhibitory activity of Ni  and  the  ability  of 
transducin to mediate the light-induced activation of cyclic 
GMP (cGMP) phosphodiesterase in the retina (3, 4). Pertussis 
toxin has been crystallized (5, 6) and purified to homogeneity 
(4). Several observations suggest that GTP regulatory proteins 
may be involved in neutrophil activation. Ns has been dem- 
onstrated in  neutrophils (7),  and  incubation of neutrophils 
with cholera toxin increases their levels of  cyclic  AMP (cAMP) 
and  inhibits their chemotactic responsiveness (8,  9).  It has 
been reported that nonhydrolyzable GTP analogues shift the 
affinity of the  formylpeptide receptors of neutrophils (10), 
and that the chemotactic peptide N-formyl-norleucyl-leucyl- 
phenylalanyl-leucyl-tyrosyl-lysine  stimulates the GTPase ac- 
tivity of human neutrophil homogenates (11). 
We therefore have tested the effect ofpretreatment of  rabbit 
peritoneal neutrophils with crystalline pertussis toxin on gran- 
ule enzyme secretion and  chemotaxis induced by the  che- 
motactic  factors,  formylmethionyl-leucyl-phenylalanine 
(fMet-Leu-Phe)', the  fragment  of the  fifth  component  of 
complement (C5a), and the arachidonic acid metabolite, leu- 
kotriene B4 (LTB4),  as well as on their stimulation  by the 
calcium  ionophore A23187  and  phorbol  12-myristate  13- 
acetate (PMA). As we shall show, pretreatment with pertussis 
toxin  inhibits  chemotactic  factor-induced chemotaxis  and 
granule enzyme secretion from the  neutrophil but  has  no 
effect on enzyme release caused  by PMA  or A23187.  No 
detectable effect of toxin treatment is evident on the binding 
Abbreviations  used in  this paper.  C5a, the  fragment of the fifth 
component of complement; fMet-Leu-Phe,  formylmethionyl-leucyl- 
phenylalanine; fNle-Leu-Phe,  formylnodeucyl-leucyl-phenylalanine; 
LTB4, leukotriene B4 [5(S), 12(R)-dihydroxy-6,  14-cis  8,  l0 trans 
eicosatetraenoic  acid]; Ni and N,, two GTP binding regulatory pro- 
teins; PMA, phorbol 12-myristate-13  acetate. 
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levels of neutrophil cAMP. 
MATERIALS AND  METHODS 
Chemicals:  The synthetic peptides fMet-Leu-Phe and formylnodeucyl- 
leucyl-phenylalanine  (fNle-Leu-Phe), A23187,  2 x  crystalline ovalbumin,  p- 
nitrophenyl-N-acetyl-/3-o-glucosaminide, and shellfish glycogen were obtained 
from Sigma Chemical Co. (St. Louis, MO). The radiolabeled peptides, fMet- 
Leu-[3H]Phe (48 Ci/mmol), fNle-Leu-[SH]Phe (42 Ci/mmol), and [3HlcAMP 
(37 Ci/mmol) were obtained from New England Nuclear (Boston, MA). CMC 
Cancer Research Chemicals was the source of the PMA, and LTB4 was a gift 
from  Dr.  P.  Borgeat (Groupe de  Recherches  sur les  Leucotrienes,  Centre 
Hospitalier de rUniversite  Laval, Sainte-Foy, Quebec, Canada). Highly purified 
C5a was a generous gift from Dr. P. M. Henson (National Jewish Hospital and 
Research Center,  Denver,  CO). The crystalline pertussis toxin  was prepared 
and dissolved as described (5). 
Rabbit peritoneal  neutrophils  obtained  4-12 h after the injection  of 200- 
400 ml of sterile 0. 1% shell fish glycogen were washed and treated as described 
(12). For granule enzyme secretion, neutrophils were suspended at a concentra- 
tion of 5 x  l06 cells/ml  in Mg2+-free modified  Hanks' buffer with  l  mg/ml 
ovalbumin. They were incubated at 37"C with or without the indicated concen- 
tration  of pertussis toxin;  at the end of the  indicated  times,  0.94  ml of cell 
suspension was added  to 50 tzl  cytochalasin  B and  l0 ul of the  stimulating 
compound, and the mixture  was incubated  for 5 min more. For chemotaxis, 
2.5 x  l06 cells/ml  were incubated  at 37"C for  l h with or without toxin, and 
the chemotactic response was measured as indicated below. 
Granule Enzyme Release:  Granule enzyme release in the presence 
of 5 ug]ml of cytochalasin B was performed as previously described (12) and 
monitored  by the  assay of lysozyme and  #-glucosaminidase.  The lysozyme 
activity  was determined  by  measuring  the  change  in  optical  density  of a 
suspension of Micrococcus  lysodeikticus as described previously (12). B-Glu- 
cosaminidase was measured by the breakdown of its substrate p-nitrophenyl-fl- 
N-acetyl glucosaminide as described (13), except that a modification by D. L. 
Kreutzer  was  followed in  which  a  300-~1 aliquot  was placed  in  a  96-well 
microtiter plate after the reaction was stopped, and the optical density was then 
determined at 410 nm with a Titertek Multiskan apparatus (Flow Laboratories, 
Inc., McLean, VA). The release of the two enzymes paralleled each other so 
that only the results for lysozyme are reported. The cells were also tested for 
lactic dehydrogenase leakage (12). No increase was found even after a 90-min 
incubation at 37"C with pertussis toxin; therefore, lactate dehydrogenase results 
are not reported. 
Chemotaxis:  Chemotaxis was carried out in a multichamber  chemo- 
taxis apparatus at 37"C for l h using 3-urn pore size filters, as described, except 
the chambers were not centrifuged (14). The mean number of cells penetrating 
below the upper monolayer  in five high-power fields (magnification  of 400) 
was averaged over duplicate filters as a measure of the chemotactic response. 
Receptor Binding:  Studies of the binding of fMet-Leu-[3H]Phe and 
fNle-Leu-[3H]Phe to rabbit peritoneal  neutrophils were performed by use of a 
modification of the silicone oil assay of Mackin et al. (15). In brief, neutrophils 
obtained 4 b after injection of  glycogen were washed twice with Mg2+-free, Ca  2÷ 
(1.7 mM)-containing Hanks' buffer and resuspended at 5 x  106 cells/ml in the 
same buffer that contained  l mg/ml crystalline bovine serum albumin (Sigma 
Chemical Co.), Cells preincubated for 1 h at 37"C in the absence (control cells) 
or presence of 500 ng/ml pertussis toxin were centrifuged and resuspended to 
either  4  x  l07  (fMet-Leu-[3HlPhe) or  l  x  l0  a cells/ml  (fNle-Leu-[3H]Phe). 
Dilutions of tritiated  peptide from l0  -m to 2 x  l0  -7 M were prepared in the 
same protein-containing  buffer as the cells. Duplicate reaction mixtures for the 
binding assay were set up at 4"C by layering 50 ul of the various dilutions of 
tritiated peptide over 500 ul Versilube F50 silicone oil (General Electric, Silicone 
Products Division, Waterford, NY) in a microfuge tube. The binding reaction 
was started by the addition  of 50 #l of the appropriate  concentration  of cells 
and stopped after 15 rain at 4"C by centrifugation in a microcentrifuge (model 
235 A; Fisher Scientific Co., Pittsburgh, PA). Nonspecific binding was measured 
in the presence of a final concentration  of l0  -5 M nonradioactive peptide. The 
free peptide  and silicone oil were aspirated  from each reaction  tube, and the 
tip of the tube that contained the cells was excised. The cell pellet was dissolved 
in 200 ul of 88% formic acid, and the cells were counted  in Rackbeta scintil- 
lation counter (model  1217; LKB Instruments, Gaithersburg, MD). 
The binding data were analyzed using a version of the LIGAND computer 
program (16) adapted for use on the Apple II computer by Dr. M. H. Teicher 
(Harvard Medical School, Cambridge, MA). The program was supplied by the 
Biomedical Computing Technology Information  Center (Vanderbilt  Medical 
Center,  Nashville, TN).  To test the  hypothesis that  toxin  treatment  had  no 
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effect on the binding  of the  peptide,  we analyzed  each  set of binding  data 
individually, then the combined  data  from control  and toxin-treated  cells in 
each experiment. The results were considered not to contradict  the hypothesis 
if the  residual variance  between the  experimental  data  and the fitted curves 
showed no significant increase in a partial  F test as a result of applying the 
constraints that the control and toxin-treated cells should exhibit equal binding 
capacities and affinities. Computer estimates of nonspecific binding were used 
throughout these analyses; however, these estimates did not differ significantly 
from the experimental values of nonspecific binding. 
Measurement of cAMP:  The unstimulated  and stimulated levels of 
intracellular cAMP in control and pertussis toxin-treated  cells were measured 
as described previously (17). Briefly, l-ml samples of washed cells (2  x  l07 
cells/ml)  suspended  in  Hanks' buffer  that contained  0.74 mM  MgCl2 were 
added to 12 x 75 mm Falcon disposable plastic tubes (Falcon Labware, Oxnard, 
CA). The reaction  was started  by the addition  of l0  -8 M fMet-Leu-Phe and 
stopped after  l rain by the addition  of 15.0 ul of 30% ice cold trichloroacetic 
acid. The denatured suspensions were frozen-thawed once. Approximately 0.07 
pmol of 3[H]-cAMP was added  to each sample  for the  determination  of the 
recovery of cAMP. The samples were centrifuged at 2,400 g for 20 min, and l 
ml of the resulting supernatant was applied to a column 0.7  x  5 cm) of AG 
50 W-X  8,  H ÷ form,  analytical  grade cation-exchange  resin,  200-400  mesh 
(Bio-Rad Laboratories,  Richmond,  CA) equilibrated with distilled water. The 
dried samples were reconstituted  in 200 ul of 0.05 M sodium  acetate buffer, 
pH  6.2  and  to determine  recovery, 50-~1 aliquots  were removed  for liquid 
scintillation counting (Delta 300; Searle Analytic Inc). Recovery of cAMP was 
generally 85-95% and was determined  for every sample. Aliquots of 50-75 tal 
were assayed for total  cAMP content  by radioimmunoassay,  which was per- 
formed  according  to  the  protocol  for nonacetylated  samples  supplied  in  a 
double antibody precipitation kit (New England Nuclear). 
RESULTS 
Inhibition  by Pertussis Toxin of Granule Enzyme 
Secretion by Chemotactic Factors 
The action of pertussis toxin shows a latent period. Incu- 
bation  of rabbit neutrophils with  10-1,000  ng/ml pertussis 
toxin  for 20  min  at  37"C  had  no discernible  effect on  the 
ability of fMet-Leu-Phe to induce secretion of lysozyme or fl- 
glucosaminidase (results not shown), whereas cells incubated 
longer were distinctly inhibited.  Neutrophils pretreated with 
I0-1,000  ng/ml toxin  for 45  min  showed appreciable but 
submaximal inhibition of granule enzyme secretion (Fig.  1); 
at  60  min,  the  inhibition  was  indistinguishable  from that 
obtained after a 90-min incubation (Fig.  1). As seen in Fig.  1, 
toxin treatment lowered the extent of release at every concen- 
tration of peptide tested. In the experiment pictured in Fig. 
I, the inhibition was essentially complete in cells incubated 
with 200-1,000 ng/ml for 60 or 90 min. However, this varied 
somewhat among the four additional experiments performed; 
in  some  preparations  of cells,  inhibition  was  much  more 
complete at  100 ng/ml than that shown in Fig.  l, whereas 
other cells were somewhat less sensitive to the action of the 
toxin. However, in all experiments, 200 ng/ml invariably gave 
maximal inhibition  after a  60-rain  incubation.  The  results 
with #-glucosaminidase paralleled those with lysozyme, and 
there was no increase in lactic dehydrogenase leakage under 
any conditions of toxin treatment. 
As is evident from Fig.  2,  pretreatment of neutrophils at 
37"C  for  60  min  with  500  ng/ml  toxin  caused  complete 
inhibition  of granule enzyme secretion induced  by C5a  or 
LTB4. Despite appearances (Fig. 2), when the corresponding 
curves were analyzed as described for the binding studies, the 
lower concentrations of LTB4 and C5a showed no significant 
differences  in  their  ability  to  release  enzyme  from  toxin- 
treated and untreated cells. The same pattern as in Fig. 2 was 
seen in one additional experiment. 50- 
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FIGURE  1  The effect of the treatment  at 37°C of rabbit  peritoneal 
neutrophils  with  varying  concentrations  of  pertussis  toxin  for  45 
min  (A),  60  min  (B),  and  90  min  (C)  on  the  ability  of the  cells  to 
secrete lysozyme  in  response to fMet-Leu-Phe.  0,  no toxin;  A,  10 
ng/ml  toxin; O,  100  ng/ml  toxin; I-l,  200  ng/ml  toxin;  &,  1,000  ng/ 
ml toxin; O, cytochalasin  B; ~I,, blank. 
Toxin Effect on Enzyme Release by PMA 
and A23187 
As Fig.  3  demonstrates,  incubation  of rabbit neutrophils 
with  500  ng/ml toxin for 60  min at 37°C  had no effect on 
lysozyme release induced by PMA. In the same experiment, 
toxin treatment completely abolished the secretagogue activity 
of fMet-Leu-Phe  plus  cytochalasin  B.  Chemotactic  factors 
require cytochalasin B to release specific and azurophil gran- 
ule contents from neutrophils in suspension, and cytochalasin 
B enhances release by A23187  (18).  PMA does not require 
cytochalasin B to induce release of specific granule constitu- 
ents  but  does  need  it  to  induce  the  secretion  of azurophil 
granule enzymes (19).  In the experiment pictured in  Fig.  3 
and  in  an  additional  experiment,  cytochalasin  B  was  not 
added to the PMA. In two other experiments not shown here, 
there  was  no  inhibition  of lysozyme or  /3-glucosaminidase 
secretion from toxin-treated neutrophils in the presence of 5 
#g/ml cytochalasin B and PMA.  Thus, neither the presence 
nor absence of cytochalasin B affects the inability of pertussis 
toxin to inhibit enzyme release by PMA. 
The calcium ionophore A23187  also induces granule en- 
zyme secretion from rabbit neutrophils (18).  Incubation of 
rabbit neutrophils with 500 ng/ml toxin for 60 min at 37°C 
had no reproducible effect on either lysozyme release induced 
by  A23187  (Fig.  4)  or  on  glucosaminidase  secretion  (not 
shown).  When  the  two curves of Fig.  2  were analyzed for 
equivalence essentially as described for the binding studies, 
the EDbo for the toxin-treated cells was 0.83 x  l0  -6 M, whereas 
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FIGURE 2  The effect of treating rabbit peritoneal neutrophils for 
60  min  at  37°C  with  500  ng/ml  of  pertussis toxin on  lysozyme 
secretion  induced by LTB4  and Cba. 0, LTB4;  ©, LTB4  +  500 ng/ml 
toxin; &, C5a; A, C5a + 500 ng/ml toxin; F-l, fMLP (10  -7 M); I, fMLP 
(10  -7 M) +  500 ng/ml  toxin; O,  blank; 0,  blank +  cytochalasin  B. 
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FIGURE 3  The lack of effect of treating rabbit peritoneal neutro- 
phils  for  60  min  at  37°C  with  500  ng/ml  of  pertussis  toxin  on 
lysozyme secretion  induced  by  PMA.  The secretion was measured 
after a  25-min  incubation  at 37°C of neutrophils with  PMA. 
that for the untreated control was 1.2 x  l0  -6 M, a small but 
statistically significant difference (P <  0.02).  However, a sec- 
ond  experiment  done  the  same way did  not  confirm this 
result--the EDbo for the toxin-treated  neutrophils was 4  x 
l0  -7 M, and that for the untreated control was 2.6 x  10  -7 (P 
>  0.1). 
Toxin Inhibition of Chemotaxis 
Fig.  5 shows that the pretreatment of neutrophils with the 
toxin also inhibited their chemotactic responsiveness to fMet- 
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FIGURE 4  The effect of treating rabbit peritoneal neutrophils for 
60  min  at  37°C with  500  ng/ml of pertussis toxin on lysozyme 
secretion induced by A23187.0, A23187; O, A23187 + 500 ng/ml 
toxin; II, fMLP (10  -7 M); r-I, fMLP,  (10  -7 M) +  500 ng/ml  toxin; A, 
blank; A, cytochalasin B. 
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The inhibition of chemotaxis induced by treating rabbit 
peritoneal neutrophils with 500 ng/ml pertussis toxin for 60 min at 
37°C. 
Leu-Phe. The sensitivity of the chemotactic reactivity to toxin 
treatment was at least as great as that of the granule enzyme 
secretory response and may be somewhat greater.  The same 
results  were  seen  in  a  duplicate  experiment.  Interestingly, 
there  appeared  to  be  no  effect  of toxin  treatment  on the 
penetration of  the filter by the cells in the unstimulated buffer 
control. 
Effect of Pertussis Toxin on FormyI 
Peptide Binding 
Three  studies  of fNle-Leu-[3H]Phe-specific binding were 
performed to assess the effect of the pretreatment of rabbit 
neutrophils with  500  ng/ml  pertussis  toxin at  37"C  for 60 
min. Scatchard plots of formyl peptide binding in one typical 
study are shown in Fig. 6. The Scatchard plots were invariably 
curved for both control and toxin-treated cells. Analysis  by 
the LIGAND computer program indicated that the data were 
consistent with the binding of fNle-Leu-[3H]Phe  to two inde- 
pendent  sets  of binding  sites: the  equilibrium  dissociation 
constants (Kd) for these  sites averaged 1.0 x  10  -9 and  1.2 x 
10  -8 M and 8%  of the sites, on average,  were  of the higher 
affinity. In the study illustrated  (Fig. 6), the fit to the complete 
experimental data for both control and toxin-treated cells was 
not significantly worsened (F =  1.29 with 4 and 20 degrees of 
freedom; P  >  0.2)  under  the  constraints  that  the  binding 
capacities  and affinities  were  unaffected by toxin treatment. 
Moreover, the experimental data points for both control and 
toxin-treated cells all  lay within  the  95%  confidence limits 
around the constrained composite curve. Data from the other 
two studies  with fNle-Leu-[3H]Phe  showed the same pattern. 
Toxin treatment again did not significantly affect the binding 
of formyl peptide to either binding site (F = 0.19 and 0.76; P 
> 0.5 in each case). 
Four studies  were performed with fMet-Leu-[3H]Phe  (data 
not shown).  The curvature of the  Scatchard plots was  less 
definitive  with this formyl peptide,  and the Kd values for the 
two sites (6.8 x  10  -~° and 4.1  x  10 -9 M) were lower than with 
fNle-Leu-[3H]Phe.  In two of the studies, toxin treatment had 
no significant  effect on the binding of this formyl peptide (F 
=  2.60 and 0.97', P >  0.05  and P >  0.5, respectively);  in the 
third  and  fourth, however,  a  small  increase  in one and de- 
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FIGURE 6  Scatchard plot of the binding of fNle-Leu-[3H]Phe  to (0) 
control rabbit peritoneal neutrophils and (O) neutrophils pretreated 
with 500 ng/ml  pertussis toxin for 60 min at 37°C. The solid  line 
represents  the  optimal  curve  fitted  by  the  LIGAND  computer 
program to the combined data for control and toxin-treated cells 
subject to the constraints that the two groups of cells have equal 
binding capacities  and affinities.  The broken lines  represent  ap- 
proximate 95% confidence limits  for data points about this  fitted 
curve. 
crease in the other in the overall  binding capacity appeared 
to occur after toxin treatment. 
Effect of Pertussis Toxin on the Basal and fMet- 
Leu-Phe-stimulated  Levels of cAMP 
We  also  examined  the  effect  of pretreatment  of rabbit 
neutrophils with toxin on the basal and fMet-Leu-Phe-stim- 
ulated rise  in intracellular level of cAMP. The results  sum- 
marized in  Table  I clearly  show that the addition  of toxin 
does not significantly affect the basal or the stimulated cAMP 
level. 
DISCUSSION 
The ability of  pertussis toxin under the appropriate conditions 
to completely inhibit chemotaxis and granule enzyme secre- 
tion induced by the chemotactic factors, fMet-Leu-Phe, C5a, 
and  LTB4 is strong evidence for the presence  of a  guanine 
nucleotide binding regulatory protein in the neutrophil iden- 
tical with or analogous to Ni or to transducin. In an abstract 
that appeared as this work was being prepared for publication, 
Goldman et al. (20) reached a similar  conclusion when they 
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Effect of Pretreatment with Pertussis Toxin on the Basal and 
fMet-Leu-Phe-stimulated cAMP in Rabbit Neutrophils 
Intracellular  level of cAMP 
Time  Basal  fMet-Leu-Phe 
min  pmol[lO r cells 
Control cells  0  6.9 _+ 0.4  9.5 _+ 0.3 
30  6.4 _  0.25  10.5 _  0.25 
60  7.0 +  0.3  9.0 _  0.15 
Toxin-treated cells  0  6.1  +  0.2  9.0 _  0.2 
(500 ng/ml)  30  6.3 +  0.3  9.9 +  0.3 
60  6.5 ___ 0.25  9.5 +  0.25 
Time  is  in  minutes at 37°C with  or without the addition of the toxin. The 
cells  were treated with  10  -a M  fMet-Leu-Phe for  1 min  before the reaction 
was  stopped.  The  values  represent  the  mean  +  SEM  of  at  least  three 
determinations. 
also found that pertussis toxin inhibits the activation of hu- 
man neutrophils by chemotactic factors. More direct evidence 
for this conclusion are the unpublished findings ofF. Okajima 
and M. Ui (referred to in reference 21) and C. K. Huang of 
this institution, that pertussis toxin induces ADP-ribosylation 
of a  41-kD  membrane protein  from guinea pig and rabbit 
neutrophils, respectively. The inhibition of neutrophil activity 
by pertussis toxin is also strong evidence that the process or 
processes that this N protein regulates plays a necessary role 
in neutrophil function. The inhibition of both enzyme secre- 
tion and chemotaxis by pertussis toxin is concentration de- 
pendent and, most tellingly, its action requires a latent period. 
Presumably, as in all other cells where it has been tested, the 
latent period is required for the pertussis toxin to bind to the 
cell and be internalized to exert its function. The neutrophil 
possesses a protein identical with or similar to Ns (7). Cholera 
toxin  which  acts through  N, to raise cAMP levels inhibits 
stimulated  neutrophil  function  (8,  9).  However,  no  matter 
what concentration of toxin or time of preincubation is used, 
the inhibition is never more than 40-50 %. This suggests that 
unlike the process regulated by the N  protein susceptible to 
pertussis toxin,  the neutrophil process or processes affected 
by Ns may not be absolutely required for cell function or that 
there  are  pathways involved in  the  cell  functions  that  are 
independent of the latter. 
One possible mechanism of the inhibition is that the toxin 
treatment  affects  chemotactic  receptor  binding.  Pertussis 
toxin treatment decreases the affinity of the D2 receptor for 
dopamine (22)  and  the  c~2-adrenergic, the  cholinergic,  and 
opiate receptors for their respective ligands (23). Garcia-Saenz 
et at. (24) have reported that pertussis toxin treatment induces 
a decreased formation of the high-affinity state for a2-adre- 
nergic agonists.  Neutrophils  contain  high-  and  low-affinity 
receptors for the formylpeptides (25, 26), and guanine nucleo- 
tides have been reported to transform the high-affinity state 
of  the formylpeptide receptor ofneutrophils and macrophages 
into  a  lower  affinity  state  (10).  However,  pertussis  toxin 
treatment of neutrophils sufficient to completely inhibit the 
secretagogue action of fMet-Leu-Phe has no detectable effect 
on  either  the  affinity  or  number  of high-  or  low-affinity 
formylpeptide binding sites.  This indicates that toxin treat- 
ment does not act on receptor binding but at some process or 
processes after receptor-chemotactic factor interaction.  It is 
unknown  whether the lack of effect of toxin treatment on 
receptor binding is because the putative N  protein does not 
mediate  changes  in  receptor affinity  or  whether,  with  the 
experimental conditions used, guanine nucleotide regulation 
of the binding site is nonexistent or not prominent. 
In many cells,  Ni is coupled to adenylate cyclase, and in 
these cells, treatment with pertussis toxin prevents the inhi- 
bition of adenylate cyclase which results from receptor-agonist 
interaction (3, 4). This does not appear to be true of chemo- 
tactic factor-receptor interaction in neutrophils. Treatment of 
neutrophils with toxin under conditions that completely in- 
hibit the ability of fMet-Leu-Phe to induce granule enzyme 
secretion has no significant effect on the level of cAMP in the 
same cells, fMet-Leu-Phe induces a rapid, transient increase 
in neutrophil intracellular cAMP (17,  27)which, however, is 
not required for the activation involved in granule secretion 
or the generation of 02- (28). Toxin treatment of the neutro- 
phils causes no change in the transient rise induced by fMet- 
Leu-Phe.  Although  it  is  not  known  whether  the  receptor- 
mediated  rise  of cAMP  occurs  through  the  activation  of 
adenylate cyclase, this finding does emphasize that the effect 
of pertussis  toxin  is  not  mediated  through  an  increase  of 
cAMP. This is again in contrast to the action of cholera toxin, 
in which the inhibitory action has been associated with such 
a rise (8, 9). Nakamura and Ui (29) have reported that cAMP 
does not appear to play a role in the inhibition of stimulated 
histamine release in rat mast cells treated with pertussis toxin. 
These findings suggest  that in both the mast cell and in the 
neutrophil, the N protein acted upon by pertussis toxin may 
not be coupled to adenylate cyclase. 
Our ignorance as to the nature of the putative GTP-binding 
regulatory protein that is the presumed target of the pertussis 
toxin  extends to  the  general  nature  of the  process that  is 
inhibited.  There are at present two possibilities. The first is 
that the toxin,  in  reacting with  its presumed neutrophil  N 
protein,  interferes  with  the  inhibition  by that  activated  N 
protein  of some  receptor-mediated process;  this  would  be 
analogous to the  manner in  which the toxin in  other cells 
interacts with N~ to prevent its inhibition ofadenylate cyclase. 
The second possibility is that the toxin, in interacting with N 
protein, prevents its activation of some necessary process; the 
analogy here is the way pertussis toxin prevents retinal trans- 
ducin from activating the cGMP phosphodiesterase (1). 
This work, although throwing no light on the function of 
the target of toxin action other than providing some examples 
of what it is not, clearly pinpoints the area in the process of 
neutrophil activation where this function is exerted. At pres- 
ent, most investigators believe that chemotactic factors such 
as  fMet-Leu-Phe,  C5a,  LTB4,  etc.,  activate  neutrophils 
through, among other things, the combined action of a rise 
in cytosolic Ca  2÷ with its resultant reactions, and the activa- 
tion of protein kinase C  and the reactions that ensue from 
this.  The  lack  of effect  of pertussis  toxin  on  the  granule 
enzyme release induced by PMA indicates that the action of 
pertussis toxin  does  not  involve the  sequence  of reactions 
initiated by the activation of protein kinase C. 
Treatment of  the cell with toxin also does not affect granule 
enzyme release initiated by the influx of Ca  2÷ caused by the 
Ca  2+ ionophore, A23187.  This is consistent with the conclu- 
sion that the final locus of toxin action is at one or more of 
the reactions that occur between chemotactic receptor stim- 
ulation and the resultant rise in intracellular Ca  2+. This con- 
clusion is also fully supported by our recent finding that the 
rise in intracellular Ca  2÷ induced by fMet-Leu-Phe or LTB4 
is  greatly  reduced  or  abolished  in  pertussis  toxin-treated 
neutrophils (30).  Which reaction or reactions is the ultimate 
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intracellular  Ca  2÷ is presently  under study.  In the course of 
this study, we have recently  found (31) that the addition of 
pertussis  toxin to rabbit  neutrophils inhibits the  fMet-Leu- 
Phe-induced  rises  in Na  + influx,  intracenular  pH,  and the 
stimulated changes in polyphosphoinositides and the phos- 
phorylation of a  46-kD protein.  Unlike the  effect  of fMet- 
Leu-Phe,  the  increases  in  Na  + influx  and  intraceUular  pH 
produced by PMA  are  not inhibited  by the toxin.  Also in 
accordance with the present  results is the recent observation 
that  exposure  of guinea  pig  neutrophils  to  pertussis  toxin 
results in a marked inhibition of the arachidonic acid release 
from these cells that occurs after chemotactic factor stimula- 
tion (referred to in references  21  and 29; see also references 
32 and  33).  After  this manuscript was submitted,  Okajima 
and Ui (32) and Bokoch and Gilman (33) published conclu- 
sions similar to those researched here. 
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Received for publication  16 November 1984, and in revised form 11 
January 1985. 
REFERENCES 
1.  Houslay,  M. D. 1984. A family of nucleotide  regulatory proteins.  Trends Biochem.  Sci. 
9:139-40. 
2.  Moss, J., and M. Vaughan. 1979. Activation of adenylate cyclase by choleragen. Annu. 
Rev. Biochem.  48:581-600. 
3.  Ui, M. 1984. Islct-activating  protein, pertussis toxin: a probe for functions of inhibitory 
guanine nucleotide  regulatory component of adenylate cyclase. Trends PharmacoL ScL 
5:277-279. 
4.  Katada, T., and M. Ui. 1982. Direct modification of the membrane adenylate cyclase 
system by islet activating protein due to ADP-ribosylation  of a  memebrane protein. 
Proc. NatL Acad. Sci.  USA. 79:3129-3133. 
5.  Sewell, W. A., J. J. Munoz, and M. A. Vadas.  1983. Enhancement of the intensity, 
duration and passive transfer of delayed hypersensitivity  by pertussigen in mice. J. Exp. 
Med. 157:2087-2096. 
6.  Arai, H., and J. J. Munoz. 1981. Crystallization  ofpertussingen from Bordetella pertussis. 
Infect. lmmun. 31:495-499. 
7.  Lad, P. M., M. M. Glovsky, P. A. Smiley, M. Klempner, D. M. Reissinger,  and J. M. 
Richards.  1984. The/3-adrenergic receptor in the human neutruphil plasma membrane: 
receptor cyclase uncoupling is associated  with amplified GTP activation.  Z  ImmunoL 
132:1466-1471. 
8.  Rivkin, 1., J.  Rosenblatt,  and  E.  L.  Pecker.  1975. The role  of cyclic  AMP in  the 
chemotactic responsiveness  and spontaneous motility of rabbit peritoneal  neutrophils. 
The inhibition  of neutrophil movement  and elevation  of cyclic AMP levels by catechol- 
amines, prostaglandins,  theophynine and cholera toxin. J. lmmunol.  115:1114-1134. 
9.  Hill,  H. R.,  R. D. Estenson,  P.  G. Quie, N. A. Hogan, and N. D. Goldberg.  1975. 
Modulation of human neutrophil chemotactic responses  by cyclic  3',  5'  guanoslne 
monophosphate and cyclic 3', 5' adenosine monophosphate. Metabolism. 24:447-456. 
10. Snyderman, R. 1984. Regulatory  mechanisms of a chemoattractant receptor on leuko- 
cytes. Fed. Proc. 43:2743-2748. 
1 I.  Hyslop,  P. A., Z. G. Oades,  A. J. Jesaitis,  R. G. Painter,  C. G. Cochrane, and L. A. 
SEar.  1984. Evidence for N-formyl chemotactic peptide-stimulated  GTPase activity in 
human neutrophil homogenates. FEBS (Fed. Eur. Bi~hem. Sot.) Lett.  166:165-169. 
12.  Showell,  J.  H., R. J.  Freer,  S. H. Zigmond, E.  Schiffmann, S. Aswanikumar, B. A. 
Coreoran, and E. L. Pecker.  1976. The structure activity relations  of synthetic  peptides 
as chemotactic factors and inducers of lysosomal  enzyme secretion  for neutrophils.  J. 
Exp. Med. 143:1154-1169, 
13.  Fantone,  J.  C.,  R.  M.  Senior,  D.  L.  Kreutzer, M.  Jones,  and  P.  A.  Ward.  1979. 
Biochemical  quantitation of the chemotactic inactivator activity in human serum. J. 
Lab. Clin. Med. 93:17-24. 
14.  Swanson,  M. J.  1977. A simple multiple chamber apparatus for measuring chemotaxis 
of polymorphonuclear leukocyles  utilizing  centrifugation  of the chamber before incu- 
bation.  J. lmmunoL Methods.  16:385-390. 
15.  Mackin, W. M., C.-K. Huang, B. J. Bormann, and E. L. Pecker.  1983. A simple and 
rapid assay for measuring radiolabeled  ligand binding to purified  plasma membranes. 
Anal. Biochem.  131:430--437. 
16.  Munson, P. J., and D. Rodbard. 1980. LIGAND: a versatile computerized approach for 
characterization  of ligand-binding  systems. Anal. Biochem.  107:220-239. 
17. Jackowski, S., and R. I. Sha'afi.  1979. Response of  adenosine cyclic 3',5' monophosphate 
level in rabbit neutrophils  to the chemotactic peptide,  formylmethionyl-leucyl-phenyl- 
alanine.  Mol. PharmacoL  16:473-478. 
18.  Showell,  H. J., P. H. Naccache, R. I. Sha'afi,  and E.  L. Pecker.  1977, The effects of 
extracellular  K  +, Na  + and Ca  2+ on lysosomal enzyme  secretion from polymorphonoclear 
leukocytes. J. lmmunol. 119:804-811. 
19.  Ringel, E. W., N. A. Sorer, and K. F. Austen. 1984. Localization  of histaminase to the 
specific granule of the human neutrophil.  Immunology. 52:649-658. 
20.  Goldman, D, W., C. A. Gifford, H. R. Bourne, and E. J. GoetzL 1984. Pertussis toxin 
(PT) inhibits  the activation of human neutruphils (Ns) to chemotactic factors (CFs). J. 
Cell. Biol. 99 (4, Pt, 2): 278a. (Abstr.) 
21.  Nakamura, T., and M. Ui. 1984. Islet-activating  protein, pertussis toxin,  inhibits  Ca  2+ 
induced and guanine nucleotide-dependent  releases of histamine and arachidonic acid 
from rat mast cells. FEBS (Fed. Eur. Biochem.  Soc. ) Lett.  173:414-4 18. 
22.  Kuno, T., O. Shirakawa,  and C. Tanaka. 1983. Selective decrease in the affinity  olD2 
dopamine  receptor  for  agonist  induced  by islet-activating  protein,  pertussis  toxin, 
associated  with  ADP-ribosylation  of the  specific  membrane protein  of the  bovine 
striatum. Biochem.  Biophys.  Res. Commun. 115:325-330. 
23.  Kurose, H.,  T.  Katada, T. Amono and M.  Ui  1983.  Specific  uncoupling by islet- 
activating protein,  pertussis toxin, of negative signal transduction via adrenergic cholin- 
ergic  and opiate receptors in  neurublastoma a  glioma hybrid cells. J.  Biol.  Chem. 
258:4870-4875. 
24.  Garcia-Saenz,  J. A., J. L. Boyer, T. Michel,  D. Sawyer, G. L. Stiles, H, Dohlman, and 
R.  J.  Lefkowitz.  1984.  Effect  of pertussis  toxin  on  a2  adrenoreceptors:  decreased 
formation of the high affinity  state  for agonists. FEBS (Fed. Eur. Biochem.  Soc.) Lett. 
172:95-98. 
25.  Mackin, W. M., C. K. Huang, and E. L. Pecker.  1982. The formylpePtide  chemotactic 
receptor on rabbit peritoneal  neutrophils.  1. Evidence for two binding sites with different 
affinities. ,L lmmunoL  129:1608-161  l. 
26.  Koo, C., R. J. Lefkowitz, and R. Snyderman. 1982. The oligopeptide chemotactic factor 
receptor on human polymorphonuclear  leukocyte membranes  exist in two affinity states. 
Biochem.  Biophys.  Res. Commun.  106:442-449. 
27.  Keller, H. U., G. Gerisch, and J. H. Wissler.  1979. A transient rise in cyclic AMP levels 
following chemotactic stimulation of neutrophil granulocytes.  Cell Biol. Int. Rep. 3:759- 
765. 
28.  Simchowitz,  L., I. Spilberg,  and J. P. Atkinson.  1983. Evidence that the functional 
responses  of human neutrophils occur independently of transient elevations  in cyclic 
AMP levels..L  Cyclic Nucleotide  Protein Phosphorylation  Res. 9:35-47. 
29.  Nakamura, T., and M.  Ui.  1983. Suppression  of passive  cutaneous anaphylaxis  by 
pertussis toxin,  an islet activating protein, as a result of inhibition  of histamine release 
from mast cells. Biochem.  Pharmacol.  32:3435-344 I. 
30.  Molski,  T. F.  P.,  P. H. Naccache, M. L. Marsh, J.Kermode, E.  L. Becker, and R.  I. 
Sha'afi.  1984. Pertussis toxin inhibits  the rise in the intracellular  concentration of free 
calcium that is induced by chemotactic factors in rabbit neutrophils:  possible role of the 
"G proteins" in calcium mobilization.  Biochem.  Biophys. Res. Commun. 124:644-650. 
31.  Volpi, M.. P. H. Naccache, T. F. P. Molski, J. Shefcyk, C.-K. Huang, M. L. Marsh, J. 
Munoz, E. L. Pecker,  and R. 1. Sha'afi.  1985. Pertussis  toxin inhibits  the formylme- 
thionyl-leucyl-phenylalanine  but not the phorbol ester stimulated changes in ion fluxes, 
protein phosphorylation and phospholipid  metabolism in rabbit neutrophils:  role of the 
"G-proteins" in excitation  response coupling.  Proc. Natl. Acad. Sci.  USA. In press. 
32.  Okajima F., and M. Ui. 1984. ADP-riposylation  of the specific membrane protein by 
islet-activating  protein,  pertussis  toxin  associated  with  inhibition  of a  chemotactic 
peptide-induced  arachidonate release in neotruphils.  A possible role of  the toxin substrate 
in Ca  2+ mobilizing biosignalling. Z Biol. Chem.  259:13863-1387  I. 
33.  Bokoch,  G. M., and A. G. Gilman.  1984. Inhibition  of receptor-mediated release of 
arachidonic acid by pertussis toxin.  Cell. 39:301-308. 
"1646  THE  JOURNAL OF  CELL BIOLOGY . VOLUME 100, 1985 